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Abstract
A number of controversies and challenges exist for the management of OA in health care. This paper
describes the challenges and gaps in OA care, particularly in relation to population health management,
complex interventions and outcomes. It sets this in the context of competing health priorities and multi-
morbidity, access to high quality conservative care, non-pharmacological therapies, resource limitations
and models of care. The overuse of some therapies and neglect of others are discussed, as well as the
potential for self-management. The roles of patient and public involvement and the healthcare team are
highlighted in enhancing best care for OA and providing solutions for closing the evidence-to-practice
gap. Implementation of models of care offer one solution to the challenges and progress of such imple-
mentation is described. Areas for further research are highlighted.
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Rheumatology key messages
. There are significant evidence-to-practice gaps in osteoarthritis care.
. Algorithms and models of care are available as examples for rheumatologists and clinics to standardized osteo-
arthritis management.
. The healthcare team can play key leadership roles in musculoskeletal education and championing excellent
osteoarthritis management.
Introduction
The Bone and Joint Decade (200010) initiated the
first international drive to prioritize OA and joint pain in
older adults and its impact on the Western world [1, 2].
The diagnostic label of OA is ranked 11th in terms of its
impact on years lived with disability. However, joint pain in
those of 45 years and over is ranked as the number one
cause of years with disability worldwide. According to
health leaders and epidemiologists, the population
trends are clear for the next 30 years, and with the
ageing population and increased obesity and physical in-
activity, joint pain and OA are set to rise.
Joint pain and OA are predominantly managed in
primary care, and while there are national and interna-
tional guidelines for the care and management of OA in
adults [such as the National Institute of Health and Care
Excellence (NICE), EULAR, Osteoarthritis Research
Society International, ACR), there is a gap between
what we know and what we do [e.g. 35]. This paper
describes the challenges and gaps in OA care, particu-
larly in relation to population health management,
interventions and outcomes. It is set in the context of
competing health priorities and multimorbidity, access
to high quality care, resource limitations and models
of care. The overuse of some therapies and neglect
of others will be discussed, as well as the potential
for self-management. Many of the challenges are
predominantly taken from experiences in the National
Health Service (NHS), UK. The role of the healthcare
team will be highlighted in enhancing best care for OA
and providing solutions for closing the evidence practice
gap.
1Institute for Primary Care and Health Sciences, Arthritis Research UK
Primary Care Centre, Keele University, Keele, UK, 2Thurston Arthritis
Research Center, University of North Carolina, Chapel Hill and
3Department of Veterans Affairs Health Care System, Center for Health
Services Research in Primary Care, Durham, NC, USA
Correspondence to: Krysia S. Dziedzic, Institute for Primary Care and
Health Sciences, Arthritis Research UK Primary Care Centre, Keele
University, Keele, ST5 5BG, UK.
E-mail: k.s.dziedzic@keele.ac.uk
Submitted 4 June 2017; revised version accepted 13 February 2018
! The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in
any medium, provided the original work is properly cited.
RHEUMATOLOGY Rheumatology 2018;57:iv88iv98doi:10.1093/rheumatology/key062
R
E
V
IE
W
Downloaded from https://academic.oup.com/rheumatology/article-abstract/57/suppl_4/iv88/4975695
by guest
on 18 April 2018
Challenges and gaps in care
Controversies in care
Data from a systematic review and meta-synthesis of quali-
tative studies exploring barriers and facilitators to offering
best OA care, for example guideline recommendations for
OA, identified only barriers and no enablers [6]. The findings
addressed system-related barriers, disease-related barriers
and patient-related barriers from which four distinct themes
emerged from eight studies [6]: OA is not that serious,
clinicians perceive they are under-prepared, to personal be-
liefs (e.g. negativity about OA), and dissonance in patient
expectations. Such findings begin to explain some of the
challenges in offering the range of treatment options recom-
mended and described in the following sections.
Making and giving a diagnosis of OA
In primary care adults 45 years and over consulting with
joint pain and limitations in everyday activity are more
likely to receive NICE recommendations if a diagnosis of
OA has been recorded in the medical electronic record [7].
Delay in diagnosis can lead to inappropriate treatment and
suboptimal care. Overuse of imaging has prompted NICE
to highlight the recommendation for diagnosing OA on
clinical grounds and set a quality standard to audit this
approach [810].
Diagnosis and subsequent treatment are often focused
on a single, most painful joint rather than multisite joint prob-
lems [11]. Yet multisite joint pain is the most common pres-
entation in consultations in primary care, and having more
joint sites affected leads to more health care consultations
irrespective of specialty or site [11]. As summarized in a
recent systematic review, there is a paucity of evidence to
guide the practitioner regarding treatment of multisite joint
pain, with few studies describing interventions for consider-
ing OA in all affected joints [12]. Comorbidities also often go
under-recognized in primary care and the community
[1316], which further hampers the holistic assessment rec-
ommended by NICE [810].
Reports have highlighted the impact of language when
giving the diagnosis of OA. Health Care Professionals’
views can be perceived to be negative, for example,
‘nothing can be done’ and ‘it’s your age’ [1720].
Unhelpful descriptions and terminology can easily transfer
from the X-ray report into the consultation, with people
with OA concerned for their ‘degenerative meniscal
tear’. Use of language to talk about OA that offers more
positive and supportive messages, such as ‘wear’ and
‘remodelling’, can enhance understanding of prognosis
when verbal messages are backed up by written patient
information [21]. Explaining that OA is part of a process of
repair rather than degeneration can introduce a sense of
optimism and reassurance because it offers a more posi-
tive outlook to life with OA, and can change patients’ and
carers’ perceptions that OA inevitably leads to persistent
pain, disability and joint replacement [21].
Self-management
One of the most complex interventions for the core man-
agement OA is self-management support. Delivering this
well through a systematic, consistent approach across the
pathway is a challenge. Ways to enhance self-manage-
ment support within consultations for OA have been stu-
died [22]. A Whole Systems Informing Self-Management
Engagement model [23] for guided self-management of
OA, including provision of patient information (e.g. OA
guidebook) [24], care responsive to patient needs [25]
and good access to follow-up care (practice nurse
consultations), has been proposed [26] (see Fig. 1).
There is still limited knowledge on how to join up a
system of care so that Quality Standards are delivered
and assessed at each point in the pathway and the roles
of the patient and carer are maximized. Patients with OA
are clear that they want help and support to self-manage
their condition, and that they want this to be health care
professional-led [2731]. Short-term changes are often
not maintained in the long term, particularly for self-man-
agement programmes that require sustained lifestyle and
behaviour changes [3237].
The beneficial effects found in systematic reviews of OA
self-management programmes, while small, demonstrate
the need for ongoing self-management support through-
out the course of the disease [3840].
The use of digital platforms to enhance service delivery
has been variable in health settings, but concerted efforts
to redesigned musculoskeletal pathways and commis-
sion the use of digital platforms to enable patient informa-
tion to transfer across systems and organisations are
growing.
Exercise and physical activity
Since 2002 we have known the benefits of exercise as
analgesia for OA pain [41, 42], but despite the substantial
evidence for clinical and cost effectiveness of exercise,
research funders still invest in underpowered studies look-
ing at exercise vs no exercise [41]. More attention is
needed on adherence to exercise, which is a major obs-
tacle in exercise programmes. Currently the OA Trial Bank
[43] is supporting work to determine subgroups who may
respond better to exercise [44]. As of 2002 sufficient evi-
dence had accumulated to show significant benefit of ex-
ercise over no exercise in patients with OA, and further
trials were deemed unlikely to overturn this result [41].
However, the review highlighted that studies continued
to be funded and published after this date. Furthermore,
additional studies continue to be underpowered; in a
Cochrane review, 35% of eligible studies recruited fewer
than 25 participants in one or both allocation groups [45].
Topical NSAIDs and paracetamol. Topical NSAIDs have
retained their role as the first line analgesia for peripheral
joint OA, and electronic templates in general practice are
known to enhance their uptake [7]. The role of paracetamol
as first line analgesia has diminished following the evi-
dence of poorer efficacy and increased side effects [46],
but despite the concerns over paracetamol clinicians are
unaware of the benefits of other therapies. Stopping inef-
fective therapies presents an implementation challenge.
Clinicians continue with paracetamol when an alternative
pharmacological or non-pharmacological approach such
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as topical NSAIDs and exercise might offer similar anal-
gesic effects with fewer side effects [7, 37].
Opioids. Opioids are frequently used for OA pain [7].
Long-term opioids may benefit those with chronic pain
but they have been shown to have adverse effects. In
the UK there is evidence of an increase in prescribing of
the more potent controlled and long-acting, long-term
opioids [47]. Bedson et al. [47] showed that whilst primary
care physicians had acted on national guidelines to
reduce their use of new opioids, in cases in which opioids
were already being prescribed, the shift towards using the
more potent controlled and long-acting opioids continued.
Those on more potent controlled opioids, either short-
acting or long-acting, are of the greatest concern in rela-
tion to prescription opioid drug abuse and addiction [47].
Surgical approaches
Surgical treatments are offered for progressive pain and
disability. The benefits of arthroscopic surgery on quality
of life over the long term are minimal, and those with knee
disease experience very small improvements in pain and
function when compared with others who receive conser-
vative management [48]. As the evidence fails to support a
persistence of benefit over the long term, there is a trade-
off between the marginal short-term benefits against the
burden of the surgical procedure [48]. Many international
guidelines do not recommend arthroscopy unless there is
true mechanical locking of the knee [e.g. 8, 49]. The use of
arthroscopy for knee OA has decreased; however, it is still
prevalent [50]. Pressure from patients to do something,
the perception that other options are limited, that
surgeons want to meet patients’ expectations, and time
pressures in clinic, all appear to influence the choice to
undertake arthroscopic procedures [50]. Winter et al. [51]
evaluated the risk of total knee replacement (TKA) in
patients undergoing knee arthroscopy. They found that
those undergoing arthroscopy might anticipate an
annual rate of TKA in the order of 2%, with higher rates
among older patients and those with more advanced OA
[51]. Clinicians and patients considering knee arthroscopy
should discuss the likelihood of subsequent TKA as they
weigh risks and benefits of surgery.
Knee OA can be managed well non-surgically, but many
patients and providers still consider total joint arthroplasty
(TJA) the only option, especially at later stages of disease
[50, 52]. Many patients have good results with TJA [49],
but there is still a subset who have sub-optimal results,
and all the factors that predict good outcome are un-
known. Data from the Osteoarthritis Initiative on patients
who had undergone TKA were used to determine the
prevalence rates of TKA surgery classified as appropriate,
inconclusive and inappropriate [53]. Approximately one-
third of TKA surgeries were judged to be inappropriate.
Surgeons have recognized the need for support tools
for making the decision for TJA [54]. Canadian stake-
holders have identified several potential criteria for TJA:
evidence of arthritis on joint examination; patient-reported
symptoms negatively impacting quality of life; an ad-
equate trial of appropriate non-surgical treatment; realistic
patient expectations of surgery; mental and physical
readiness of the individual for surgery; and patient-sur-
geon agreement that potential benefits exceed risks [55].
However, there remains a need for validated tools to
adequately assess and communicate appropriateness
criteria for TJA.
For patients with no previous history of knee repair sur-
gery and with very minimal OA changes, autologous chon-
drocyte implantation may offer a treatment option for
those with persistent symptoms after conservative ther-
apy and with cartilage defects over 2 cm2 [56]. However,
FIG. 1 A model OA consultation developed using the WISE model and tested in the MOSAICS study
MOSAICS: Managing OSteoArthritis in ConsultationS.
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there remains a need for evidence on long-term effective-
ness of this procedure.
Training gap
Consensus work and surveys highlight the need for health
care professionals’ training in the skills of making and
giving the diagnosis of OA, supporting self-management
and delivering care in line with international guideline rec-
ommendations for OA [e.g. 57]. Audit of educational
needs of health care professionals and patients shows
the mismatch between educational need and training de-
livered [58]. Education and training packages for primary
health care professionals now offer accredited online
musculoskeletal modules [e.g. 59, 60].
Maximizing the use of transferable skills by health care
professionals has been neglected. For example, general
practice nurses have expertise in running chronic disease
clinics, and many of the techniques for supporting self-
management, for example, keeping active and weight
management, can be used across long term conditions.
Unfortunately, general practice nurses are given few train-
ing opportunities to enhance their skills in supporting
self-management for OA.
Outcomes of care
The whole research cycle takes research from priority set-
ting right through to implementation of best evidence.
Whether the same outcomes used to demonstrate clinical
effectiveness in trials are the same as those needed for
evaluation of services remains unclear. Allen et al. [4] in
their evaluation of models of care listed commonly used
outcomes that included disease-specific measures for OA
as well as generic health measures and OA quality indica-
tors of care [e.g. 61, 62]. New measures, such as the
Musculoskeletal Health Questionnaire (MSK-HQ), may
also be useful for assessing outcomes of care [63] and
offer an opportunity to embed outcome measures in
routinely recorded medical record data. Big data and
aggregated, anonymized medical record data will provide
the means for understanding variations in care at an
organization level [e.g. 64]. The challenges of information
governance, consent, anonymization and aggregation of
data are very difficult issues to resolve and are often
tackled only at a local level.
Closing the evidence-to-practice gap
Given the current challenges in offering guideline recom-
mendations, closing the evidence-to-practice gap is key.
From 2002 the Arthritis and Musculoskeletal Alliance in
the UK developed standards of care for OA, building on
what a person with OA should expect to receive but their
implementation has been lacking [65]. With the advent of
NICE OA guidelines [8, 9] and NICE Quality Standards [10]
we now have a set of recommendations that can be
adopted, but as yet there has been no UK audit of these.
These gaps in knowledge are recognized, and yet clos-
ing the gap is complex [66]. The evidence we produce
regarding how to deliver best care has its own limitations.
The individual studies themselves can be methodologically
outstanding and serve to increase knowledge, but trans-
ferring this knowledge to real world settings is difficult.
Evidence underpinning the recommendations for clinical
guidelines is predominantly derived from studies of knee
OA, with fewer studies for the hip and even fewer for the
hand and foot. Single treatment approaches are often stu-
died in isolation and there is a lack of studies of integrated
packages of care.
Lau et al. [66] described the causes of the evidence-to-
practice gap in primary care and the ways in which the evi-
dence gap could be addressed, although even the most
effective interventions such as clinical opinion leaders
show at best only small effects, and there is no certainty
that multiple approaches work better [66]. What Lau and
colleagues did highlight was the importance of context
and the role of organizations in influencing the uptake of
best practice. Context means policy such as NICE guide-
lines, public awareness of OA and its care, economic cli-
mate and funding, stakeholder buy-in (e.g. Sustainability
Transformation Partnerships), technological advances and
infrastructure to deliver best care.
For health services, Clinical Networks can offer an ap-
proach to knowledge mobilization between ‘what we
know’ and ‘what we do’. The National Clinical Director
for Long Term Conditions with NHS England and the
Arthritis and Musculoskeletal Alliance have made muscu-
loskeletal health a priority across the four key regions
in England with the development of musculoskeletal
knowledge networks to embody the potential for sharing
models of care and good practice with trusted partners
within a geographic boundary [67].
OA care models and pathways to
enhance coordination
Many of the specific gaps in OA care can be at least partly
attributed to a lack of care coordination and a purposeful
management approach. Without a model for how, when and
by whom specific OA-related therapies are provided, there is
a high risk that some components of care will be neglected.
This can be particularly challenging since OA treatments are
delivered by different types of providers, yet a point person
is not always apparent. Another challenge is that although
OA treatment guidelines provide information about therapies
that should be delivered, they are largely silent regarding
when specific treatments are appropriate and how various
therapies may best fit together in a comprehensive treatment
approach. Unfortunately, research to date has provided little
evidence regarding the optimal timing, integration or criteria
for different OA therapies. However, a number of efforts
have applied practical, clinical experience to OA treatment
guidelines, developing treatment algorithms and care
models that can serve as guides and examples for rheuma-
tologists and other clinicians.
Development of OA treatment algorithms
Two recent international efforts developed clinical
algorithms for OA treatment [6870]. Meneses et al. [69]
performed a systematic review of OA treatment guidelines
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and then used an iterative expert panel process to derive
clinical algorithms for the treatment of hand, hip and knee
OA. These algorithms consider key issues such as comor-
bid health conditions and offer a step-wise approach for
delivery of pharmacological and non-pharmacological
therapies. The algorithms also provide general decision
rules for when more intensive or different therapies
should be considered. An example algorithm for a patient
with knee OA and several comorbidities is shown in Fig. 2;
four different algorithms are available and can provide a
practical approach for rheumatologists and clinics to op-
erationalize treatment of OA. Bruye´re and colleagues [68]
also developed algorithms that focus on pharmacother-
apy for knee OA.
Example models of OA care
There have also been efforts internationally to develop
models for delivering recommended OA therapies within
health systems. A selection of these models is described
briefly here and in greater detail elsewhere [4]. These
models vary in terms of the range of OA treatments included
(e.g. some focusing on a specific area such as weight
management or physical activity and some with a more
comprehensive approach), types of providers involved and
reimbursement model. Therefore, these programmes pro-
vide a range of examples that rheumatologists can consider
with respect to feasibility of implementation in their clinical
context.
Amsterdam Osteoarthritis Cohort—Netherlands
Individuals from the Amsterdam Osteoarthritis Cohort are
eligible for an OA management programme if they have
hip and/or knee OA, and if pain is non-traumatic, sufficient
to seek care and attributed by a clinician to a hip or knee
joint. This programme offers coordinated multidisciplinary
management that includes supervised exercise according
to a knee joint stabilization programme [71], occupational
therapy, psychological support and medical management.
Funding for this programme is from various sources,
including the health care system and trials conducted
within the cohort.
Better management of patients with OA—Sweden
Better Management of Patients with Osteoarthritis [72] is
a programme for individuals with hip, knee, hand or
shoulder OA [73] who have non-traumatic pain, sufficient
to seek care and attributed by a clinician to their joint.
In this programme physiotherapists, occupational
therapists and expert patients (OA-communicators)
provide education, self-management support, exercise
recommendations, an optional individualized exercise
programme and optional supervised exercise group
sessions.
There is also an online version, Joint Academy [74],
which includes recommended exercises, interactive les-
sons, reports and tracking tools. In addition, patients can
communicate with a physical therapist in the context of
the online programme. Participants from anywhere in the
world can sign up for Joint Academy, and the current
cost for the 6-week core programme is $45USD.
Enabling Self-management and Coping with Arthritic Pain
Using Exercise—UK
Enabling Self-management and Coping with Arthritic
Pain using Exercise (ESCAPE-pain) [75] is a rehabilitation
programme for people with joint pain, including OA [42].
It integrates self-management and coping strategies with
and individualized exercise programme. ESCAPE-pain
is typically delivered by physiotherapists but can be
administered by other qualified healthcare workers in
various settings. The delivery format is in small groups,
with meetings twice per week for 6 weeks. There is also
an ESCAPE-pain app that mirrors the in-person
programme.
Good Life with Arthritis in Denmark
Good Life with Arthritis in Denmark (GLA:D) is programme
for individuals with hip and/or knee OA; similar to Better
Management of Patients with Osteoarthritis, patients must
have non-traumatic pain sufficient to seek care and attrib-
uted by a clinician to OA of the hip or knee joint. GLA: D
focuses on self-management and exercise components of
OA treatment [76]. There are three patient education ses-
sions provided over the course of 2 weeks; the first two
sessions are delivered by a physiotherapist and the third
by an expert patient who previously participated in GLA:D.
These education sessions are followed by 12 sessions of
supervised neuromuscular exercise sessions based on the
NEuroMuscular Exercise programme [77]. GLA:D has now
been disseminated in many countries, and more informa-
tion (as well as contact information for the developers) can
be found on the GLA: D website [78].
Joint Implementation of Osteoarthritis Guidelines—UK
Joint Implementation of Osteoarthritis Guidelines [79] is a
comprehensive OA management programme based on
evidence from the MOSAICS trial [26]. This programme
is offered to individuals of 45 years and over who are
consulting in general practice, have knee, hip, hand and/
or foot OA and have joint pain that limits function. The
programme is initiated with a model OA consultation
with a general practitioner and a practice nurse, including
making, giving and explaining the OA diagnosis, giving an
OA guidebook, offering analgesia and referral to a practice
nurse (Fig. 1). The practice nurse then provides up to four
sessions supporting self-management; these include
exercise and physical activity advice using Arthritis
Research UK booklets, weight management and support
for pain relief. An electronic template is used to measure
key quality indicators of OA care within the programme.
Further implementation of this model is being tested in the
Netherlands, Norway, Denmark and Portugal (European
Institute of Innovation & Technology (EIT)-Health funded
Joint Implementation of oSteoArthritis Guidelines in
Western Europe (JIGSAW-E )) [80].
Osteoarthritis Chronic Care Programme—Australia
Osteoarthritis Chronic Care Programme is a programme for
patients with doctor-diagnosed knee and/or hip OA, along
with pain in the affected joint on most days of the past month
(pain visual analogue scale 54 out of 10) [81, 82]. This
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FIG. 2 Clinical algorithms for OA treatment of the knee with several co-morbidities
Reprinted from Osteoarthritis and Cartilage, Volume 24, Meneses SR, Goode AP, Nelson AE, Lin J, Jordan JM, Allen KD
et al. Clinical algorithms to aid osteoarthritis guideline dissemination, Pages 148799, Copyright 2016, with permission
from the Osteoarthritis Research Society International, published by Elsevier Ltd [69].
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programme involves multidisciplinary, individually tailored,
physiotherapy-led OA management. Treatments include ex-
ercise, diet, psychological support, occupational therapy,
orthotics and medical management. Patients can be referred
to the programme by any health care provider, and it was
initially funded through the public hospital system. (The
Osteoarthritis Chronic Care Programme model of care and
other relevant documents can be accessed at [83].)
Osteoarthritis Healthy Weight for Life—Australia
The Osteoarthritis Healthy Weight For Life programme [84]
is offered to individuals with knee or hip OA diagnosed by
radiological evidence who are overweight (BMI5 28) and
have significant joint symptoms [85]. This 18-week pro-
gramme focuses on behavioural aspects of OA manage-
ment, including weight loss and improved nutrition, a
physical activity plan and physiotherapist-delivered exer-
cises (strength, balance and mobility), personalized online
symptom, progress and satisfaction tracking (with phone or
mail options) and personal motivation via phone or other
tools. This programme is available in Australia at no
charge via some health insurance providers, but for those
without private health insurance (a substantial proportion of
the population) there is a cost involved.
Roles of the multidisciplinary team
The multidisciplinary team of health care professionals, for
example, rheumatology nurse, physiotherapist, community
pharmacist, dietician and rheumatologist, can assist with
transferable skills and increase confidence in primary care
in delivering quality care, reduce overuse of X-ray in the
diagnosis of OA, reduce inappropriate referral to orthopaedic
surgery and increase the uptake of core non-pharmaco-
logical treatment with confidence in the safety of exercise
and its use as an analgesic [86].
The role of rheumatologist in OA
management
OA is most often managed in primary care, with referral to
secondary care typically only in more advanced stages or
complex presentations. However, rheumatologists have a
key role and opportunity for leadership in OA management
[59]. First, rheumatologists have content expertise in the
management of OA and can therefore be leaders in health
systems, driving appropriate models of care and quality
improvement. Leadership in this area is greatly needed,
considering the gaps in quality of OA care and often a
lack of a champion for treatment of this health condition.
Second, OA commonly co-occurs with other rheumatic
conditions, particularly among older adults. Therefore,
rheumatologists can set an example of delivering the high-
est quality of OA care, incorporating both pharmacological
and non-pharmacological therapies. The following are spe-
cific practical recommendations for ways rheumatologist
can lead the way in optimizing OA care:
Provide education and support in OA management to
primary care colleagues
Because primary care providers are responsible for mana-
ging a wide range of health conditions, it is not realistic to
expect they will typically be experts in musculoskeletal
medicine. Rheumatologists can bridge this gap by providing
periodic educational sessions on OA care for primary care
providers, covering evidence-based therapies and specific
challenging clinical situations. In some health care settings,
individual rheumatologists or groups of rheumatology clin-
icians may be able to provide virtual or electronic consults to
provide input on specific patients or scenarios. This may be
particularly useful for rural primary care providers who do not
have ready in-person access to musculoskeletal expertise.
Provide leadership in developing an OA patient
pathway or model of care within the healthcare
system
The example algorithms and models of care described
above can be an excellent starting place for developing a
context-appropriate OA pathway. Because of content area
expertise, rheumatologists are equipped to lead multidis-
ciplinary efforts (involving primary care, orthopaedics and
rehabilitation) to develop and implement pathways that fa-
cilitate evidence-based and comprehensive OA care.
Connect with community organizations and resources
Behavioural treatments such as exercise and weight loss
are key components of managing OA. Resources to sup-
port patients in these behaviours are often not available
within the healthcare system. However, many services are
available within the community. Rheumatologists can
have a significant impact on patients’ OA management
by connecting them with evidence-based, reputable com-
munity resources to support healthy behaviours.
Involving the patients and the public
Rheumatology has developed a successful track record of
involving patients and the public in shaping OA care path-
ways. Patients and the public have an increasing and in-
fluential role in shaping services and supporting changes
in practice in primary care, and their role in secondary
care has been established for some time.
Key areas for future research
Algorithms and models of care are available as examples
for rheumatologists and clinics to standardize OA man-
agement and the healthcare team can play key leadership
roles in musculoskeletal education and championing ex-
cellent OA management. However, there are significant
evidence-to-practice gaps in OA care. The following are
research areas and methodological considerations that
would significantly improve the evidence base underlying
optimal OA management: research participants should
represent the range of patients seen for OA, including
those with multi-joint disease, those with multiple com-
orbidities and the oldest old. This will enhance the
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generalizability of findings so that they can inform real-
world clinical practices; studies should systematically
examine heterogeneity of treatment effects to identify pa-
tient characteristics that predict response to therapies.
This will help to inform tailoring of treatment regimens in
clinical settings; although studies of individual treatments
or interventions are still needed in some areas, there is a
great need to study more novel, complex and integrated
approaches to OA management that mirror clinical scen-
arios, consider the whole person and engage with
caregivers and other support systems; there is a need
for a greater focus on implementation research in OA,
identifying models of care that can be successfully de-
livered, as well as considerations for cost effectiveness.
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